Apr 18 |
Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
|
Apr 11 |
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
|
Mar 29 |
Blueprint Medicines Corporation (NASDAQ:BPMC): When Will It Breakeven?
|
Mar 28 |
Insiders Are Dumping These 10 Healthcare Stocks
|
Mar 22 |
CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
|
Mar 21 |
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report?
|
Mar 17 |
30 Biggest Biotechnology Companies in the World
|
Mar 15 |
Blueprint Medicines Corp's Chief Commercial Officer Sells Company Shares
|
Mar 12 |
Moderna (MRNA) Soars 8.7%: Is Further Upside Left in the Stock?
|
Mar 6 |
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|